We are live on ! Find out more
FRTX

Fresh Tracks Therapeutics, Inc. Common Stock
FRTX

Delisted

FRTX was delisted on the 18th of December, 2023.

Back to rankings

78 hedge funds and large institutions have $41.7M invested in Fresh Tracks Therapeutics, Inc. Common Stock in 2014 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 16 increasing their positions, 19 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

334% more call options, than puts

Call options by funds: $317K | Put options by funds: $73K

2% more capital invested

Capital invested by funds: $41.1M → $41.7M (+$634K)

9% less first-time investments, than exits

New positions opened: 10 | Existing positions closed: 11

1% less funds holding

Funds holding: 79 → 78 (-1)

16% less repeat investments, than reductions

Existing positions increased: 16 | Existing positions reduced: 19

Holders
78
Holders Change
-1
Holders Change %
-1.27%
% of All Funds
2.25%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
16
Reduced
19
Closed
11
Calls
$317K
Puts
$73K
Net Calls
+$244K
Net Calls Change
+$264K

Top Buyers

Rank Fund Capital Flow
1
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$1.42M
2
TC
TFS Capital
Pennsylvania
+$973K
3
Vanguard Group
Vanguard Group
Pennsylvania
+$464K
4
SFM
Sphera Funds Management
Israel
+$424K
5
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
+$268K

Top Sellers

Rank Fund Capital Flow
1
AI
Ariel Investments
Illinois
-$1.79M
2
LM
Litespeed Management
New York
-$1.64M
3
Invesco
Invesco
Georgia
-$617K
4
VAM
Visium Asset Management
New York
-$590K
5
OAM
Oxford Asset Management
United Kingdom
-$563K
Name Holding Trade Value Shares
Change 		Change in
Stake
VKH
26
Virtu KCG Holdings
New York
$111K +$62.5K +14 +108%
BCM
27
Bridgeway Capital Management
Texas
$110K – – –
HK
28
Horizon Kinetics
New York
$109K – – –
CCM
29
Condor Capital Management
New Jersey
$108K +$103K +23 +767%
VOYA Investment Management
30
VOYA Investment Management
Georgia
$107K – – –
ProShare Advisors
31
ProShare Advisors
Maryland
$99K +$107K +24 New
Citigroup
32
Citigroup
New York
$96K +$4.46K +1 +4%
Wellington Management Group
33
Wellington Management Group
Massachusetts
$94K +$103K +23 New
Goldman Sachs
34
Goldman Sachs
New York
$93K -$44.6K -10 -30%
RhumbLine Advisers
35
RhumbLine Advisers
Massachusetts
$84K -$4.46K -1 -5%
EAM
36
Evanson Asset Management
California
$81K – – –
BA
37
BlackRock Advisors
Delaware
$81K +$4.46K +1 +5%
OAM
38
Oxford Asset Management
United Kingdom
$80K -$563K -126 -86%
RCM
39
Rotella Capital Management
Washington
$80K +$89.3K +20 New
State Board of Administration of Florida Retirement System
40
State Board of Administration of Florida Retirement System
Florida
$76K – – –
NFA
41
Nationwide Fund Advisors
Ohio
$75K – – –
AQR Capital Management
42
AQR Capital Management
Connecticut
$67K – – –
AIG
43
American International Group
New York
$66.6K – – –
CS
44
Credit Suisse
Switzerland
$64K – – –
EWM
45
Evercore Wealth Management
New York
$62K – – –
CCM
46
Coldstream Capital Management
Washington
$59K -$22.3K -5 -25%
GC
47
Guggenheim Capital
Illinois
$55K +$40.2K +9 +180%
BMM
48
Berkshire Money Management
Massachusetts
$49K +$17.9K +4 +50%
Susquehanna International Group
49
Susquehanna International Group
Pennsylvania
$43K – – –
Morgan Stanley
50
Morgan Stanley
New York
$39K -$246K -55 -85%
1
2
3 4

FRTX Hedge Fund Activity: Q1 2014 in Review

78 of the 3,464 institutional investors tracked by Wall St. Rank reported a position in Fresh Tracks Therapeutics, Inc. Common Stock (FRTX) for Q1 2014, worth a combined $41.7M — up 1.5% from $41.1M a quarter earlier.

Sellers outnumbered buyers: 11 funds closed out of FRTX and 10 opened new positions — a net loss of 1 holder — while 19 trimmed existing stakes and 16 added.

The largest buyer was D.E. Shaw & Co, adding an estimated $1.42M. The largest seller was Ariel Investments, cutting an estimated $1.79M.

  • 78 institutional investors held Fresh Tracks Therapeutics, Inc. Common Stock (FRTX) as of Q1 2014, down from 79 in Q4 2013.
  • Funds reported $41.7M of Fresh Tracks Therapeutics, Inc. Common Stock stock for Q1 2014, up 1.5% quarter-over-quarter.
  • 10 funds opened new Fresh Tracks Therapeutics, Inc. Common Stock positions in Q1 2014 and 11 closed out, a net change of -1 holder.
  • The largest Fresh Tracks Therapeutics, Inc. Common Stock buyer in Q1 2014 was D.E. Shaw & Co, an estimated $1.42M added.
  • The largest Fresh Tracks Therapeutics, Inc. Common Stock seller in Q1 2014 was Ariel Investments, an estimated $1.79M sold.

Based on aggregated 13F filings for Q1 2014.